We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

112 hedge funds and large institutions have $403M invested in BioDelivery Sciences International, Inc. in 2014 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

566% more call options, than puts

Call options by funds: $13.1M | Put options by funds: $1.96M

178% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 9

38% more capital invested

Capital invested by funds: $293M → $403M (+$110M)

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

33% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 33

17% more funds holding

Funds holding: 96112 (+16)

Holders
112
Holders Change
+16
Holders Change %
+16.67%
% of All Funds
3.22%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
25
Increased
44
Reduced
33
Closed
9
Calls
$13.1M
Puts
$1.96M
Net Calls
+$11.1M
Net Calls Change
+$14.9M
Name Holding Trade Value Shares
Change
Change in
Stake
SI
51
Shaker Investments
Ohio
$869K +$683K +72,000 New
Group One Trading
52
Group One Trading
Illinois
$785K -$1.25M -131,439 -67%
TA
53
Teachers Advisors
New York
$750K +$93K +9,804 +19%
Charles Schwab
54
Charles Schwab
California
$725K +$99.5K +10,500 +21%
AQR Capital Management
55
AQR Capital Management
Connecticut
$678K +$210K +22,200 +65%
Jane Street
56
Jane Street
New York
$630K +$495K +52,230 New
LOM
57
Loeb Offshore Management
New York
$594K -$934K -98,548 -67%
NFA
58
Nationwide Fund Advisors
Ohio
$593K +$195K +20,599 +72%
AIG
59
American International Group
New York
$569K +$250K +26,326 +126%
EIM
60
Essex Investment Management
Massachusetts
$546K +$131K +13,803 +44%
DC
61
Deere & Company
Illinois
$544K -$364K -38,401 -46%
EMG
62
Ellington Management Group
Connecticut
$508K +$399K +42,100 New
MLICM
63
Metropolitan Life Insurance Company (MetLife)
New York
$499K +$140K +14,741 +55%
Morgan Stanley
64
Morgan Stanley
New York
$483K -$272K -28,662 -42%
MC
65
Menta Capital
California
$447K +$351K +37,000 New
Janney Montgomery Scott
66
Janney Montgomery Scott
Pennsylvania
$447K +$64.5K +6,800 +23%
ICAP
67
Independence Capital Asset Partners
Colorado
$442K +$347K +36,591 New
SIC
68
Salem Investment Counselors
North Carolina
$409K
AllianceBernstein
69
AllianceBernstein
Tennessee
$401K +$314K +33,068 +25,052%
RhumbLine Advisers
70
RhumbLine Advisers
Massachusetts
$399K +$75.2K +7,928 +32%
ACS
71
Archford Capital Strategies
Illinois
$399K
PCM
72
Potomac Capital Management
New York
$377K -$161K -17,001 -35%
Capital Fund Management (CFM)
73
Capital Fund Management (CFM)
France
$372K +$292K +30,800 New
PPA
74
Parametric Portfolio Associates
Washington
$371K +$292K +30,777 New
CCB
75
Cutter & Co Brokerage
Missouri
$349K +$8.53K +900 +3%

BDSI Hedge Fund Activity: Q2 2014 in Review

112 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q2 2014, worth a combined $403M — up 38% from $293M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new BDSI positions and 9 closed out — a net gain of 16 holders — while 44 added to existing stakes and 33 trimmed.

The largest buyer was Oak Ridge Investments, opening a new position worth an estimated $13.1M. The largest seller was Deerfield Management, cutting an estimated $25.2M.

  • 112 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q2 2014, up from 96 in Q1 2014.
  • Funds reported $403M of BioDelivery Sciences International, Inc. stock for Q2 2014, up 38% quarter-over-quarter.
  • 25 funds opened new BioDelivery Sciences International, Inc. positions in Q2 2014 and 9 closed out, a net change of +16 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q2 2014 was Oak Ridge Investments, an estimated $13.1M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q2 2014 was Deerfield Management, an estimated $25.2M sold.

Based on aggregated 13F filings for Q2 2014.